InvestorsHub Logo
icon url

ladavis23

07/25/14 3:36 PM

#31137 RE: sts66 #31136

Lose perspective?

If I told you 1 year ago today (shortly after the dilution of last summer)that AMRN would get run over at ADCOM 9-2, have their ANCHOR SPA reneged, what would you have told me?? Remember the conversations at that time about the dilution? Shareholders were up in arms, believing that this was a prelude to ANCHOR denial. Many of the same clowns here were saying the same thing.. "the dilution has nothing to do with the company believing ANCHOR is in trouble, its putting the company in a stronger position for approval, don't lose focus, Anchor is the prize...", yada yada yada. Remember that? It is easy to make the broad case of everything that you said. All makes complete sense. But it is naive to think that AMRN has a clear path to R-it and no one can tarnish, block, or come in the way of it. Please.

Current price action meaningless? Really? In Jun 2012 stock traded $14.50ish. Since Dec 2012 after GIA announcement, the stock has been the leading indicator for every single disastrous event the company has had. Basically straight down. You have been around long enough to witness this. And currently this pattern is continuing, even now. The company refused to negotiate with the FDA back in Jan. They wanted EVERYTHING. You know of ajax to be a smart guy, as do I. The end game has already been made for NCE and SPA. Many people on this board might not want to admit it publicly, but privately they know this. NCE will be denied, many here will spin and say it's no big deal. SPA appeal will either get denied, or passed along. Then, AMRN will file first amendment, win, Larry, Moe and Curly will collect there cash bonuses this year, and we will be left with a meaningless "win" that will do nothing for shareholders, or the stock, beyond get excited for 100-150 weekly script growth.

Tell me why I am wrong....
icon url

no_mo_Butterfinger

07/25/14 3:42 PM

#31138 RE: sts66 #31136

"how can the FDA torpedo Re-IT if it's successful as most believe it will be? " The same way they did the successful, met all endpoints, slam dunk ANCHOR I guess. The same way they rescinded a legal SPA? I don't know what they will change or claim isn't true or needed, any more. All I know it, I don't trust them AT ALL.
I'm just saying I am no longer blinded by a 'sure thing' when it comes to the FDA
icon url

investorfreak69

07/25/14 3:46 PM

#31139 RE: sts66 #31136

What outrage? The same outrage that has gotten us nowhere with Anchor? Please......Dr's don't care.
icon url

BioChica

07/25/14 4:35 PM

#31151 RE: sts66 #31136

I think it will change the fundamentals of, how physicians treat the disease. They will focus more on inflammatory markers rather than lipid levels alone. If the Zetia outcomes trial fails this fall, a lot of doctors out there, will be scratching their heads.

IMPROVE-IT
Enrollment: 18141
Study Start Date: October 2005
Estimated Study Completion Date: September 2014